Bones, Migraines, and the Weird Liver Finding You've Never Heard Of

Episode Script

Thanks Toni. We've got a genuinely interesting mix today — buckle in. Actually, no — you know I hate that phrase. Just, keep listening.

So, endometriosis. Most people think of it as a reproductive-years condition. You have it during your periods, it causes pain and chaos, and then menopause comes and the estrogen drops and it's... done. That's the general understanding, and for most women, it mostly holds.

Mostly.

A case report published this week in PubMed, authored by Pan and colleagues, describes a postmenopausal woman who developed a giant cyst — and when they say giant, they mean it, this thing was large enough to show up clearly on serial CT scans over time — on her liver. Not on her ovaries. Not on her uterus. On her liver. And when they biopsied it, it was endometriotic tissue.

Now, I want to be careful here because a case report is exactly what it sounds like. One patient. One set of images. One clinical story. It is not a study you can generalize from. It doesn't tell us how common this is, and it doesn't change clinical guidelines. What it does is flag something real — that endometriosis can deposit tissue in places far outside the pelvis, a pattern called extrapelvic endometriosis, and that in rare circumstances, those deposits can apparently persist or even grow after menopause.

The question the authors raise is about estrogen. If a postmenopausal woman is on hormone replacement therapy, she has circulating estrogen again — and endometriotic tissue is estrogen-sensitive. So theoretically, HRT could feed tissue that would otherwise have gone quiet. This is not a new concern in the research literature; there have been discussions for years about whether women with a history of endometriosis need a different approach to HRT than women without it. But it remains an area without clean, definitive answers.

What I'd want any listener who had endometriosis to take from this: it is worth flagging your history to your menopause specialist if you're considering HRT, or if you're already on it and start having any unexplained abdominal symptoms. This case is rare. It should not make anyone panic. But it's a useful reminder that menopause doesn't necessarily wipe the slate completely clean on a condition you had before it.

The liver location is genuinely unusual, and the CT imaging over time — showing the cyst changing — is what makes this case worth reporting. It's a teaching case. Radiologists and gynecologists seeing this in their training are more likely to think of endometriosis when they see a puzzling liver cyst in a postmenopausal woman. That kind of awareness does eventually make its way into better diagnoses. It just takes time.

---

Bone thinning after menopause is one of those topics that gets mentioned constantly and understood rarely. A review published in a peer-reviewed journal and authored by Yong and colleagues — published October 1st — takes what they call a "life-course approach" to preventing and managing osteoporosis after menopause. And I actually think this framing is more useful than the usual conversation, which tends to start at age 65 when a doctor finally orders a bone density scan.

Here's the basic biology in plain words: you spend your whole life building and breaking down bone. Up until around your late 20s or early 30s, you're building more than you're breaking. After that, it's roughly even. Then menopause hits, estrogen drops sharply, and the breakdown starts winning — sometimes quite fast. The first five to seven years after your last period are when bone loss is most rapid. That window matters a lot.

The review makes the case that prevention isn't something you start after menopause — it's something that pays off when you build bone density earlier in life, and then protect what you have during and after the transition. Calcium and vitamin D are the classic recommendations, and they're still in the review, but the authors give a lot of space to things that get less attention: resistance training, protein intake, smoking cessation, limiting alcohol. These are not gentle suggestions. They have real supporting evidence for bone health specifically.

On strength training: the research here is consistent. Loading your skeleton — meaning lifting weights, doing resistance work — is one of the most reliable ways to slow bone loss. Your bones respond to mechanical stress by maintaining density. Sitting still, they don't get that signal. This isn't controversial in the research. It's just underemphasized compared to the calcium conversation.

Protein is another one that doesn't get enough attention in the context of bone health. There's a tendency to think of protein as a muscle thing, but bone is a living tissue and it needs protein too. The review supports adequate protein intake — which for women over 45 tends to be higher than most of us actually eat.

The review also covers the role of hormone therapy in bone protection. Estrogen therapy is actually one of the most effective tools for preventing bone loss in the early postmenopausal years. That's not opinion — that's well-established in the literature. The conversation around whether to use it is more nuanced and depends on an individual's full health picture, but its effect on bone is not really debated.

What I'd push back on slightly is the framing around bone density scans. Standard guidance in many countries recommends starting routine scans at 65. The review acknowledges that women with early menopause — before age 45 — or those with other risk factors should be scanned earlier. I think that earlier screening conversation happens less often than it should in clinical practice. If you had early menopause, or you smoke, or you've been on steroids long-term, or you have a family history of fractures, asking your doctor about an earlier scan is completely reasonable. The scan itself is called a DEXA scan, it's low-radiation, it's quick, and it gives you an actual number to work with instead of guessing.

The life-course framing in this review is the right instinct. Bone health is not a problem that appears at 65. It's a process that's been building for decades. The menopause transition is just where the urgency becomes visible.

---

The last piece of research is one I find genuinely worth paying attention to, and it comes from a nationwide cohort study out of South Korea, authored by Kim and colleagues, published in July. They looked at over four million women — so the size here is not the issue — and asked whether menopause changes the relationship between migraine and cardiovascular disease risk.

The short version: yes, it does.

Women who have migraines already carry a somewhat higher risk of heart disease and stroke than women who don't. This has been established in the literature for a while. What this study adds is the observation that after menopause, that gap grows. Migraine appears to become a stronger risk factor for cardiovascular problems once a woman has gone through the menopause transition.

Now, this is an observational study. It shows a pattern in a very large population. It cannot tell us why this is happening or whether migraine is directly causing anything. There are a number of possible explanations — changes in how blood vessels behave after menopause, shared inflammatory pathways between migraine and heart disease, hormonal shifts that affect both — but none of those is proven here. The study finds an association; it doesn't find a mechanism.

What the authors suggest is that women with a history of migraine should be considered higher-priority for cardiovascular monitoring as they go through and after menopause. Not alarm-bell high-priority, but the kind of heightened attention that translates to: make sure your blood pressure is checked regularly, make sure your cholesterol is on someone's radar, make sure the migraines you're having are part of the clinical conversation.

The thing that makes this study hard to immediately act on is that we don't yet know whether treating the migraines better reduces the cardiovascular risk. That's the logical next question and it hasn't been answered. So right now, this is useful for awareness and for making sure the dots get connected between neurology and cardiology in women's care — two departments that don't always talk to each other — rather than a call to change treatment.

If you have migraines and you're in perimenopause or past it, this is a reasonable thing to bring up with whoever manages your heart health. Not because you should be scared, but because you are exactly the kind of patient this research is pointing toward. Four million women is a hard dataset to shrug off.

---

Sources curated automatically by the Hot Flasher pipeline.